Skip to content
Biodatica
Start free

Investigator

Amy Lynn Baxter

MMJ LABS, LLC · funded by NIDA

Companies
2

Resolved onto their grants.

Grants
2

Federal awards on file.

Non-dilutive funding
$803k

Summed across those awards.

First award
Sep 1, 2023

On this record.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R44

    Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)

    $456k

    Sep 1, 2023NIDAMMJ LABS, LLCNIH RePORTER · 11240717 (opens the source filing in a new tab)

  2. R44

    Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)

    $347k

    Sep 1, 2023NIDAMMJ LABS, LLCNIH RePORTER · 11257679 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources